Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Survival outcomes after treatment of cancer of the oral cavity (1985-2015).

Zanoni DK, Montero PH, Migliacci JC, Shah JP, Wong RJ, Ganly I, Patel SG.

Oral Oncol. 2019 Mar;90:115-121. doi: 10.1016/j.oraloncology.2019.02.001. Epub 2019 Feb 15.

PMID:
30846169
2.

Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, Barron DA, Zehir A, Jordan EJ, Omuro A, Kaley TJ, Kendall SM, Motzer RJ, Hakimi AA, Voss MH, Russo P, Rosenberg J, Iyer G, Bochner BH, Bajorin DF, Al-Ahmadie HA, Chaft JE, Rudin CM, Riely GJ, Baxi S, Ho AL, Wong RJ, Pfister DG, Wolchok JD, Barker CA, Gutin PH, Brennan CW, Tabar V, Mellinghoff IK, DeAngelis LM, Ariyan CE, Lee N, Tap WD, Gounder MM, D'Angelo SP, Saltz L, Stadler ZK, Scher HI, Baselga J, Razavi P, Klebanoff CA, Yaeger R, Segal NH, Ku GY, DeMatteo RP, Ladanyi M, Rizvi NA, Berger MF, Riaz N, Solit DB, Chan TA, Morris LGT.

Nat Genet. 2019 Feb;51(2):202-206. doi: 10.1038/s41588-018-0312-8. Epub 2019 Jan 14.

PMID:
30643254
3.

American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence-based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodules.

Meltzer CJ, Irish J, Angelos P, Busaidy NL, Davies L, Dwojak S, Ferris RL, Haugen BR, Harrell RM, Haymart MR, McIver B, Mechanick JI, Monteiro E, Morris JC 3rd, Morris LGT, Odell M, Scharpf J, Shaha A, Shin JJ, Shonka DC Jr, Thompson GB, Tuttle RM, Urken ML, Wiseman SM, Wong RJ, Randolph G.

Head Neck. 2019 Apr;41(4):843-856. doi: 10.1002/hed.25526. Epub 2018 Dec 18.

PMID:
30561068
4.

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA.

J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440. doi: 10.6004/jnccn.2018.0089.

PMID:
30545990
5.

Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer.

Shaha AR, Migliacci JC, Nixon IJ, Wang LY, Wong RJ, Morris LGT, Patel SG, Shah JP, Tuttle RM, Ganly I.

Surgery. 2019 Jan;165(1):6-11. doi: 10.1016/j.surg.2018.04.078. Epub 2018 Nov 8.

PMID:
30415873
6.

Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules.

Marcadis AR, Valderrabano P, Ho AS, Tepe J, Swartzwelder CE, Byrd S, Sacks WL, Untch BR, Shaha AR, Xu B, Lin O, Ghossein RA, Wong RJ, Marti JL, Morris LGT.

Surgery. 2019 Jan;165(1):17-24. doi: 10.1016/j.surg.2018.04.062. Epub 2018 Oct 22.

PMID:
30360906
7.

International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data.

Wu CW, Dionigi G, Barczynski M, Chiang FY, Dralle H, Schneider R, Al-Quaryshi Z, Angelos P, Brauckhoff K, Brooks JA, Cernea CR, Chaplin J, Chen AY, Davies L, Diercks GR, Duh QY, Fundakowski C, Goretzki PE, Hales NW, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Miyauchi A, Orloff L, Rastatter JC, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Stack BC Jr, Tolley NS, Slycke SV, Snyder SK, Urken ML, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo M, Randolph GW.

Laryngoscope. 2018 Oct;128 Suppl 3:S18-S27. doi: 10.1002/lary.27360. Epub 2018 Oct 6. Review.

PMID:
30291765
8.

International neural monitoring study group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal.

Schneider R, Randolph GW, Dionigi G, Wu CW, Barczynski M, Chiang FY, Al-Quaryshi Z, Angelos P, Brauckhoff K, Cernea CR, Chaplin J, Cheetham J, Davies L, Goretzki PE, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Orloff L, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Singer MC, Snyder SK, Tolley NS, Van Slycke S, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo M, Dralle H.

Laryngoscope. 2018 Oct;128 Suppl 3:S1-S17. doi: 10.1002/lary.27359. Epub 2018 Oct 5. Review.

PMID:
30289983
9.

The Role of Maxillofacial Prosthetics for the Surgically Treated Patient at National Cancer Institute-Designated Comprehensive Cancer Centers.

Rosen EB, Palin CL, Huryn JM, Wong RJ.

Laryngoscope. 2019 Feb;129(2):409-414. doi: 10.1002/lary.27330. Epub 2018 Sep 24.

PMID:
30247745
10.

Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease.

Beckham TH, Romesser PB, Groen AH, Sabol C, Shaha AR, Sabra M, Brinkman T, Spielsinger D, McBride S, Tsai CJ, Riaz N, Tuttle RM, Fagin JA, Sherman EJ, Wong RJ, Lee NY.

Thyroid. 2018 Sep;28(9):1180-1189. doi: 10.1089/thy.2018.0214.

PMID:
30105947
11.

Validation and assessment of discordance of the 8th edition AJCC (American Joint Committee on Cancer) clinical and pathologic staging systems in patients with p16+ oropharyngeal cancer treated with surgery and adjuvant radiation at a single institution.

Gupta P, Migliacci JC, Hay A, Rosenthal M, Mimica X, Lee N, Wong RJ, Shah J, Patel S, Ganly I.

Oral Oncol. 2018 Aug;83:140-146. doi: 10.1016/j.oraloncology.2018.06.024. Epub 2018 Jun 23. No abstract available.

PMID:
30098770
12.

Activity of roniciclib in medullary thyroid cancer.

Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ.

Oncotarget. 2018 Jun 15;9(46):28030-28041. doi: 10.18632/oncotarget.25555. eCollection 2018 Jun 15.

13.

Potent effects of roniciclib alone and with sorafenib against well-differentiated thyroid cancer.

Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ.

Endocr Relat Cancer. 2018 Oct;25(10):853-864. doi: 10.1530/ERC-18-0150. Epub 2018 Jun 12.

PMID:
29895526
14.

An In Vivo Murine Sciatic Nerve Model of Perineural Invasion.

Deborde S, Yu Y, Marcadis A, Chen CH, Fan N, Bakst RL, Wong RJ.

J Vis Exp. 2018 Apr 23;(134). doi: 10.3791/56857.

PMID:
29733315
15.

Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas.

Desrichard A, Kuo F, Chowell D, Lee KW, Riaz N, Wong RJ, Chan TA, Morris LGT.

J Natl Cancer Inst. 2018 Dec 1;110(12):1386-1392. doi: 10.1093/jnci/djy060.

PMID:
29659925
16.

Patterns of recurrence in oral tongue cancer with perineural invasion.

Cracchiolo JR, Xu B, Migliacci JC, Katabi N, Pfister DG, Lee NY, Patel SG, Ghossein RA, Wong RJ.

Head Neck. 2018 Jun;40(6):1287-1295. doi: 10.1002/hed.25110. Epub 2018 Mar 9.

PMID:
29522275
17.

Surgical management of the recurrent laryngeal nerve in thyroidectomy: American Head and Neck Society Consensus Statement.

Fundakowski CE, Hales NW, Agrawal N, Barczyński M, Camacho PM, Hartl DM, Kandil E, Liddy WE, McKenzie TJ, Morris JC, Ridge JA, Schneider R, Serpell J, Sinclair CF, Snyder SK, Terris DJ, Tuttle RM, Wu CW, Wong RJ, Zafereo M, Randolph GW.

Head Neck. 2018 Apr;40(4):663-675. doi: 10.1002/hed.24928. Epub 2018 Feb 20.

PMID:
29461666
18.

Effects of roniciclib in preclinical models of anaplastic thyroid cancer.

Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ.

Oncotarget. 2017 Jul 8;8(40):67990-68000. doi: 10.18632/oncotarget.19092. eCollection 2017 Sep 15.

19.

Inflammatory Monocytes Promote Perineural Invasion via CCL2-Mediated Recruitment and Cathepsin B Expression.

Bakst RL, Xiong H, Chen CH, Deborde S, Lyubchik A, Zhou Y, He S, McNamara W, Lee SY, Olson OC, Leiner IM, Marcadis AR, Keith JW, Al-Ahmadie HA, Katabi N, Gil Z, Vakiani E, Joyce JA, Pamer E, Wong RJ.

Cancer Res. 2017 Nov 15;77(22):6400-6414. doi: 10.1158/0008-5472.CAN-17-1612. Epub 2017 Sep 26.

20.

Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.

Tuttle RM, Fagin JA, Minkowitz G, Wong RJ, Roman B, Patel S, Untch B, Ganly I, Shaha AR, Shah JP, Pace M, Li D, Bach A, Lin O, Whiting A, Ghossein R, Landa I, Sabra M, Boucai L, Fish S, Morris LGT.

JAMA Otolaryngol Head Neck Surg. 2017 Oct 1;143(10):1015-1020. doi: 10.1001/jamaoto.2017.1442.

21.

Association of Number of Dissected Lymph Nodes With Survival in Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma Patients Undergoing Primary Surgery: A Population-Based Analysis.

Tsai CJ, Zheng J, Zhang Z, Riaz N, Baxi SS, Wong RJ, Lee NY.

JAMA Otolaryngol Head Neck Surg. 2017 Oct 1;143(10):1049-1052. doi: 10.1001/jamaoto.2017.0947. No abstract available.

22.

Positron-emission tomography enhancement after vocal fold injection medialization.

Grant N, Wong RJ, Kraus DH, Schoder H, Branski RC.

Ear Nose Throat J. 2017 Jun;96(6):218-224.

PMID:
28636732
23.

How Schwann cells facilitate cancer progression in nerves.

Deborde S, Wong RJ.

Cell Mol Life Sci. 2017 Dec;74(24):4405-4420. doi: 10.1007/s00018-017-2578-x. Epub 2017 Jun 19. Review.

24.

Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models.

Lin SF, Lin JD, Hsueh C, Chou TC, Yeh CN, Chen MH, Wong RJ.

Oncotarget. 2017 Jun 20;8(25):41294-41304. doi: 10.18632/oncotarget.17180.

25.

Complications following transoral robotic surgery (TORS): A detailed institutional review of complications.

Hay A, Migliacci J, Karassawa Zanoni D, Boyle JO, Singh B, Wong RJ, Patel SG, Ganly I.

Oral Oncol. 2017 Apr;67:160-166. doi: 10.1016/j.oraloncology.2017.02.022. Epub 2017 Feb 28.

26.

A Proposal to Redefine Close Surgical Margins in Squamous Cell Carcinoma of the Oral Tongue.

Zanoni DK, Migliacci JC, Xu B, Katabi N, Montero PH, Ganly I, Shah JP, Wong RJ, Ghossein RA, Patel SG.

JAMA Otolaryngol Head Neck Surg. 2017 Jun 1;143(6):555-560. doi: 10.1001/jamaoto.2016.4238.

27.

A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.

Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ.

PLoS One. 2017 Feb 16;12(2):e0172315. doi: 10.1371/journal.pone.0172315. eCollection 2017.

28.

Screening for thyroid cancer in survivors of childhood and young adult cancer treated with neck radiation.

Tonorezos ES, Barnea D, Moskowitz CS, Chou JF, Sklar CA, Elkin EB, Wong RJ, Li D, Tuttle RM, Korenstein D, Wolden SL, Oeffinger KC.

J Cancer Surviv. 2017 Jun;11(3):302-308. doi: 10.1007/s11764-016-0588-6. Epub 2016 Dec 27.

29.

Impact of Flap Reconstruction on Radiotoxicity After Salvage Surgery and Reirradiation for Recurrent Head and Neck Cancer.

Ho AS, Zumsteg ZS, Meyer A, Riaz N, Rahmati R, Kraus DH, McCarthy C, Wong RJ, Shah JP, Lee NY.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):850-857. Epub 2016 Aug 9.

30.

The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.

Morris LG, Chandramohan R, West L, Zehir A, Chakravarty D, Pfister DG, Wong RJ, Lee NY, Sherman EJ, Baxi SS, Ganly I, Singh B, Shah JP, Shaha AR, Boyle JO, Patel SG, Roman BR, Barker CA, McBride SM, Chan TA, Dogan S, Hyman DM, Berger MF, Solit DB, Riaz N, Ho AL.

JAMA Oncol. 2016 Jul 21. doi: 10.1001/jamaoncol.2016.1790. [Epub ahead of print]

31.

Mechanisms of Perineural Invasion.

Bakst RL, Wong RJ.

J Neurol Surg B Skull Base. 2016 Apr;77(2):96-106. doi: 10.1055/s-0036-1571835. Epub 2016 Mar 10. Review.

32.

Schwann cells induce cancer cell dispersion and invasion.

Deborde S, Omelchenko T, Lyubchik A, Zhou Y, He S, McNamara WF, Chernichenko N, Lee SY, Barajas F, Chen CH, Bakst RL, Vakiani E, He S, Hall A, Wong RJ.

J Clin Invest. 2016 Apr 1;126(4):1538-54. doi: 10.1172/JCI82658. Epub 2016 Mar 21.

33.

Ethical Considerations When Counseling Patients With Thyroid Cancer About Surgery vs Observation.

Morris LG, Wong RJ, Tuttle RM.

JAMA Otolaryngol Head Neck Surg. 2016 Apr;142(4):406-7. doi: 10.1001/jamaoto.2016.0038. No abstract available.

34.

External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society.

Kiess AP, Agrawal N, Brierley JD, Duvvuri U, Ferris RL, Genden E, Wong RJ, Tuttle RM, Lee NY, Randolph GW.

Head Neck. 2016 Apr;38(4):493-8. doi: 10.1002/hed.24357. Epub 2015 Dec 30.

35.

Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).

Suárez AL, Louis P, Kitts J, Busam K, Myskowski PL, Wong RJ, Chen CS, Spencer P, Lacouture M, Pulitzer MP.

J Am Acad Dermatol. 2015 Dec;73(6):968-75. doi: 10.1016/j.jaad.2015.08.041. Epub 2015 Oct 2.

36.

Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinoma.

Dutta PR, Riaz N, McBride S, Morris LG, Patel S, Ganly I, Wong RJ, Palmer F, Schöder H, Lee N.

Head Neck. 2016 Apr;38 Suppl 1:E1285-93. doi: 10.1002/hed.24213. Epub 2015 Sep 3.

37.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: TIMING OF MULTIPLE ENDOCRINE NEOPLASIA THYROIDECTOMY AND EXTENT OF CENTRAL NECK LYMPHADENECTOMY.

Lairmore TC, Diesen D, Goldfarb M, Milas M, Ying AK, Sharma J, McIver B, Wong RJ, Randolph G; AACE Endocrine Surgery Scientific Committee.

Endocr Pract. 2015 Jul;21(7):839-47. doi: 10.4158/EP14463.DSCR. Review. No abstract available.

PMID:
26172129
38.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER.

Davies L, Morris LG, Haymart M, Chen AY, Goldenberg D, Morris J, Ogilvie JB, Terris DJ, Netterville J, Wong RJ, Randolph G; AACE Endocrine Surgery Scientific Committee.

Endocr Pract. 2015 Jun;21(6):686-96. doi: 10.4158/EP14466.DSCR. Review.

39.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: POSTOPERATIVE HYPOPARATHYROIDISM--DEFINITIONS AND MANAGEMENT.

Stack BC Jr, Bimston DN, Bodenner DL, Brett EM, Dralle H, Orloff LA, Pallota J, Snyder SK, Wong RJ, Randolph GW.

Endocr Pract. 2015 Jun;21(6):674-85. doi: 10.4158/EP14462.DSC. Review. No abstract available. Erratum in: Endocr Pract. 2015 Oct;21(10):1187. Dosage error in article text.

PMID:
26135962
40.

Intraoperative real-time reflectance confocal microscopy for guiding surgical margins of lentigo maligna melanoma.

Hibler BP, Cordova M, Wong RJ, Rossi AM.

Dermatol Surg. 2015 Aug;41(8):980-3. doi: 10.1097/DSS.0000000000000401. No abstract available.

41.

AACE/ACE disease state clinical review: pancreatic neuroendocrine incidentalomas.

Herrera MF, Åkerström G, Angelos P, Grant CS, Hoff AO, Pantoja JP, Pérez-Johnston R, Sahani DV, Wong RJ, Randolph G.

Endocr Pract. 2015 May;21(5):546-53. doi: 10.4158/EP14465.DSC. Review.

42.

Definitive chemoradiation for primary oral cavity carcinoma: A single institution experience.

Scher ED, Romesser PB, Chen C, Ho F, Wuu Y, Sherman EJ, Fury MG, Wong RJ, McBride S, Lee NY, Riaz N.

Oral Oncol. 2015 Jul;51(7):709-15. doi: 10.1016/j.oraloncology.2015.04.007. Epub 2015 May 7.

43.

Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules.

Marti JL, Avadhani V, Donatelli LA, Niyogi S, Wang B, Wong RJ, Shaha AR, Ghossein RA, Lin O, Morris LG, Ho AS.

Ann Surg Oncol. 2015 Nov;22(12):3996-4001. doi: 10.1245/s10434-015-4486-3. Epub 2015 Apr 11.

44.

Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates.

Ho AS, Davies L, Nixon IJ, Palmer FL, Wang LY, Patel SG, Ganly I, Wong RJ, Tuttle RM, Morris LG.

Cancer. 2015 Jun 1;121(11):1793-9. doi: 10.1002/cncr.29289. Epub 2015 Feb 24.

45.

The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.

He S, He S, Chen CH, Deborde S, Bakst RL, Chernichenko N, McNamara WF, Lee SY, Barajas F, Yu Z, Al-Ahmadie HA, Wong RJ.

Mol Cancer Res. 2015 Feb;13(2):380-90. doi: 10.1158/1541-7786.MCR-14-0303. Epub 2014 Oct 13.

46.

Silk-elastin-like protein polymer matrix for intraoperative delivery of an oncolytic vaccinia virus.

Price DL, Li P, Chen CH, Wong D, Yu Z, Chen NG, Yu YA, Szalay AA, Cappello J, Fong Y, Wong RJ.

Head Neck. 2016 Feb;38(2):237-46. doi: 10.1002/hed.23877. Epub 2015 Jun 16.

47.

Results of a prospective thyroid ultrasound screening program in adenomatous polyposis patients.

Steinhagen E, Hui VW, Levy RA, Markowitz AJ, Fish S, Wong RJ, Sood R, Ochman SM, Guillem JG.

Am J Surg. 2014 Nov;208(5):764-769. doi: 10.1016/j.amjsurg.2014.03.012. Epub 2014 Jun 20.

PMID:
25073656
48.

Successful perioperative use of prothrombin complex concentrate in the treatment of acquired factor X deficiency in the setting of systemic light-chain (AL) amyloidosis.

Litvak A, Kumar A, Wong RJ, Smith L, Hassou H, Soff G.

Am J Hematol. 2014 Dec;89(12):1153-4. doi: 10.1002/ajh.23813. Epub 2014 Aug 27. No abstract available.

49.

A nomogram to predict loco-regional control after re-irradiation for head and neck cancer.

Riaz N, Hong JC, Sherman EJ, Morris L, Fury M, Ganly I, Wang TJ, Shi W, Wolden SL, Jackson A, Wong RJ, Zhang Z, Rao SD, Lee NY.

Radiother Oncol. 2014 Jun;111(3):382-7. doi: 10.1016/j.radonc.2014.06.003. Epub 2014 Jun 30.

50.

External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer.

Romesser PB, Sherman EJ, Shaha AR, Lian M, Wong RJ, Sabra M, Rao SS, Fagin JA, Tuttle RM, Lee NY.

J Surg Oncol. 2014 Sep;110(4):375-82. doi: 10.1002/jso.23656. Epub 2014 Jun 24.

PMID:
24961938

Supplemental Content

Loading ...
Support Center